You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Datopotamab Deruxtecan

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

Metastatic Non Small Cell Lung Cancer Trial in Japan (Datopotamab Deruxtecan, Pembrolizumab, Pemetrexed)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Datopotamab Deruxtecan
  • +4 more
  • Fukuoka, Japan
  • +3 more
Jan 13, 2023

Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)

Recruiting
  • Advanced or Metastatic NSCLC
  • Datopotamab deruxtecan
  • +4 more
  • Santa Ana, California
  • +15 more
Dec 13, 2022

Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Pembrolizumab, Carboplatin)

Recruiting
  • Advanced or Metastatic NSCLC
  • Datopotamab deruxtecan
  • +3 more
  • Scottsdale, Arizona
  • +24 more
Jun 3, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Triple Negative Breast Cancer
  • Datopotamab Deruxtecan (Dato-DXd)
  • Beijing, China
  • +27 more
Aug 11, 2022

Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in Japan, United States (Datopotamab

Recruiting
  • Hormone Receptor Positive Breast Cancer
  • +2 more
  • Datopotamab Deruxtecan (Dato-DXd)
  • Los Angeles, California
  • +13 more
Jun 21, 2022

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Datopotamab Deruxtecan, Pembrolizumab)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Chandler, Arizona
  • +32 more
Aug 12, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)

Recruiting
  • NSCLC
  • Datopotamab deruxtecan
  • +6 more
  • Phoenix, Arizona
  • +227 more
Jan 17, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Jonesboro, Arkansas
  • +142 more
Oct 31, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +165 more
Jan 17, 2023

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

NSCLC Trial in Worldwide (DS-1062a)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Phoenix, Arizona
  • +82 more
Jul 27, 2022

Metastatic Lung Cancer Trial in Villejuif (DS-1062a)

Recruiting
  • Metastatic Lung Cancer
  • Villejuif, France
    Gustave Roussy
Jun 17, 2021

NSCLC Trial in Worldwide (DS-1062a, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Chandler, Arizona
  • +203 more
Jun 9, 2022

Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)

Suspended
  • Osteosarcoma
  • Recurrent Osteosarcoma
  • Trastuzumab Deruxtecan
  • Birmingham, Alabama
  • +27 more
Oct 21, 2022

Brain Metastases, Adult Trial in Durham (Patritumab deruxtecan)

Not yet recruiting
  • Brain Metastases, Adult
  • Patritumab deruxtecan
  • Durham, North Carolina
    Duke University Medical Center
Jan 19, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab

Not yet recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 20, 2023

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

Recruiting
  • Early-stage Breast Cancer
  • +6 more
  • Fullerton, California
  • +8 more
Sep 19, 2022